A new proposal to reduce the price Americans have to pay for medicines by importing medicines from Canada overlooks patient risks that will not outweigh any potential cost savings. There is also no system to assure the safety and quality of medicine that was not intended for the U.S. market if is it exported to the U.S. from Canada. Read more here.
Last Updated on May 12, 2020 by Aimed Alliance
